NO320047B1 - Sammensetning for oral administrering - Google Patents

Sammensetning for oral administrering Download PDF

Info

Publication number
NO320047B1
NO320047B1 NO20001585A NO20001585A NO320047B1 NO 320047 B1 NO320047 B1 NO 320047B1 NO 20001585 A NO20001585 A NO 20001585A NO 20001585 A NO20001585 A NO 20001585A NO 320047 B1 NO320047 B1 NO 320047B1
Authority
NO
Norway
Prior art keywords
composition
levosimendan
active ingredient
weight
polymorphic form
Prior art date
Application number
NO20001585A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001585D0 (no
NO20001585L (no
Inventor
Ilka Larma
Maarit Harjula
Saila Antila
Lasse Lehtonen
Maarit Backman
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20001585D0 publication Critical patent/NO20001585D0/no
Publication of NO20001585L publication Critical patent/NO20001585L/no
Publication of NO320047B1 publication Critical patent/NO320047B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001585A 1997-09-26 2000-03-27 Sammensetning for oral administrering NO320047B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI973804A FI973804A7 (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia
PCT/FI1998/000753 WO1999016443A1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan

Publications (3)

Publication Number Publication Date
NO20001585D0 NO20001585D0 (no) 2000-03-27
NO20001585L NO20001585L (no) 2000-03-27
NO320047B1 true NO320047B1 (no) 2005-10-17

Family

ID=8549609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001585A NO320047B1 (no) 1997-09-26 2000-03-27 Sammensetning for oral administrering

Country Status (35)

Country Link
US (1) US6355269B1 (cs)
EP (1) EP1014987B1 (cs)
JP (1) JP4493840B2 (cs)
KR (1) KR100762022B1 (cs)
CN (1) CN1149994C (cs)
AR (1) AR013519A1 (cs)
AT (1) ATE260659T1 (cs)
AU (1) AU732489B2 (cs)
BG (1) BG64746B1 (cs)
BR (1) BR9813213A (cs)
CA (1) CA2304702C (cs)
CZ (1) CZ294984B6 (cs)
DE (1) DE69822172T2 (cs)
DK (1) DK1014987T3 (cs)
EA (1) EA001647B1 (cs)
EE (1) EE03854B1 (cs)
ES (1) ES2217580T3 (cs)
FI (1) FI973804A7 (cs)
GE (1) GEP20032943B (cs)
HR (1) HRP20000171B1 (cs)
HU (1) HUP0003757A3 (cs)
ID (1) ID24486A (cs)
IL (1) IL134802A (cs)
MX (1) MXPA00002956A (cs)
MY (1) MY118156A (cs)
NO (1) NO320047B1 (cs)
NZ (1) NZ503207A (cs)
PL (1) PL190862B1 (cs)
PT (1) PT1014987E (cs)
RS (1) RS49708B (cs)
SI (1) SI1014987T1 (cs)
SK (1) SK283187B6 (cs)
TR (1) TR200000635T2 (cs)
WO (1) WO1999016443A1 (cs)
YU (1) YU17700A (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI980902A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI20000577A0 (fi) * 2000-03-13 2000-03-13 Orion Yhtymae Oy Pyridatsinyylifenyylihydratsoneja
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
MXPA03005496A (es) 2000-12-22 2004-05-14 Baxter Int Metodo para preparar suspensiones de submicroparticulas.
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
CA2767946A1 (en) * 2009-07-14 2011-01-20 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
CN104418810A (zh) * 2013-09-04 2015-03-18 北京博时安泰科技发展有限公司 一种左西孟旦的合成新路线
CN103554032A (zh) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法
ITMI20132185A1 (it) * 2013-12-23 2015-06-24 Edmond Pharma Srl Polimorfi di levosimendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン
CN111548310B (zh) * 2020-05-12 2021-07-02 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型及其制备方法
CN111718299B (zh) * 2020-07-23 2023-03-10 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型b及其制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
MY118156A (en) 2004-09-30
AU732489B2 (en) 2001-04-26
YU17700A (sh) 2002-10-18
SI1014987T1 (en) 2004-08-31
NO20001585D0 (no) 2000-03-27
MXPA00002956A (es) 2003-05-19
PT1014987E (pt) 2004-06-30
EE03854B1 (et) 2002-10-15
GEP20032943B (en) 2003-04-25
ATE260659T1 (de) 2004-03-15
BG104250A (en) 2000-12-29
ID24486A (id) 2000-07-20
CZ2000919A3 (cs) 2000-09-13
NO20001585L (no) 2000-03-27
FI973804A0 (fi) 1997-09-26
FI973804A7 (fi) 1999-03-27
AU9350698A (en) 1999-04-23
HUP0003757A2 (hu) 2001-05-28
DE69822172D1 (de) 2004-04-08
EA200000360A1 (ru) 2000-10-30
CN1149994C (zh) 2004-05-19
JP2001517702A (ja) 2001-10-09
SK283187B6 (sk) 2003-03-04
HK1032001A1 (en) 2001-07-06
BR9813213A (pt) 2000-08-29
CZ294984B6 (cs) 2005-04-13
CA2304702C (en) 2007-09-04
RS49708B (sr) 2007-12-31
BG64746B1 (bg) 2006-02-28
JP4493840B2 (ja) 2010-06-30
KR20010030679A (ko) 2001-04-16
AR013519A1 (es) 2000-12-27
EP1014987B1 (en) 2004-03-03
IL134802A0 (en) 2001-04-30
HRP20000171B1 (en) 2009-06-30
CN1271282A (zh) 2000-10-25
HUP0003757A3 (en) 2001-07-30
IL134802A (en) 2004-01-04
KR100762022B1 (ko) 2007-09-28
US6355269B1 (en) 2002-03-12
SK3842000A3 (en) 2000-09-12
PL339461A1 (en) 2000-12-18
PL190862B1 (pl) 2006-02-28
ES2217580T3 (es) 2004-11-01
NZ503207A (en) 2001-04-27
EA001647B1 (ru) 2001-06-25
EP1014987A1 (en) 2000-07-05
DK1014987T3 (da) 2004-05-24
EE200000187A (et) 2001-04-16
TR200000635T2 (tr) 2000-09-21
CA2304702A1 (en) 1999-04-08
HRP20000171A2 (en) 2000-12-31
DE69822172T2 (de) 2005-02-24
WO1999016443A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
CA2304702C (en) Oral compositions of levosimendan
JP5086069B2 (ja) 重硫酸アタザナビルおよび新規形態の製造方法
JPH0643400B2 (ja) トラセミドの安定な変態の製法
US5354760A (en) Crystalline Tiagabine monohydrate, its preparation and use
US6180789B1 (en) Method for obtaining pure enantiomers of a pyridazinone derivative
US6703410B1 (en) Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide
US9593117B2 (en) Crystalline form of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
MXPA03005884A (es) Hemimaleato de amlodipina.
EP3004102A1 (en) Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1 h-pyrazol-3-ylamino)-6-ethyl-1 -methyl-1,6-dihydroimidazo[4,5- d]fy rrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
WO2014193865A1 (en) Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1 h-pyrazol-3-ylamino)-6-ethyl-1 -methyl-1,6-dihydroimidazo[4,5- d]fy rrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
EP3004104A1 (en) Crystalline form of n,n-dicyclopropyl-4-(1,5-dimethyl-1 h-pyrazol-3-ylamino)-6-ethyl-1 -methyl-1,6-dihyrdroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders
ZA200302520B (en) Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl] piperazine.hydrochloride.
WO2025203051A1 (en) Ribociclib succinate form c and process thereof
US20050215600A1 (en) Polymorphs of torsemide hydrochloride and process for production thereof
HK1032001B (en) Oral compositions of levosimendan

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees